Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 109
Filter
1.
Mol Cell Biochem ; 421(1-2): 1-18, 2016 Oct.
Article in English | MEDLINE | ID: mdl-27543111

ABSTRACT

Anemia is a relatively common symptom coexisting with colorectal carcinoma. Besides having a positive impact on hematological parameters, erythropoietin (Epo) has the serious adverse effect of promoting the neoplastic process. The role of Epo in colon cancer has not been clearly shown. The aim of this study was to assess the effects of Epo therapy on colorectal carcinoma cells both in in vitro and in animal models. Human colon adenocarcinoma cells DLD-1 and Ht-29 were cultured in medium with Epo beta in normoxia. Cell proliferation was measured with an automated cell counter. Expression of erythropoietin receptor (EpoR) mRNA, Akt mRNA, and their proteins were assessed by RT-PCR and confocal microscopy, respectively. Nude mice were inoculated with adenocarcinoma cells and treated with a therapeutic dose of Epo. Expression of EpoR, VEGF, Flt-1 and CD31 was evaluated in xenograft tumors. We identified that Epo through EpoR activates Akt, which promotes colon cancer cell growth and proliferation. Epo, and high levels of phosphorylated EpoR, directly accelerates tumor growth through its proliferative and proangiogenic effects. This study demonstrated that Epo had enhanced carcinogenesis through increase of EpoR and Flt-1 expression, and thereby contributed to tumor development. These results suggest that both EpoR-positive and EpoR-negative cancer cells could be regulated by exogenous Epo. However, an increased response to erythropoietin was observed in the EpoR-positive cells. Thus, erythropoietin increases the risk of tumor progression in colon cancer and should not be used to treat anemia in this type of cancer.


Subject(s)
Adenocarcinoma/blood supply , Adenocarcinoma/metabolism , Erythropoietin/metabolism , Neoplasm Proteins/metabolism , Neovascularization, Pathologic/metabolism , Receptors, Erythropoietin/metabolism , Adenocarcinoma/pathology , Animals , Cell Line, Tumor , Heterografts , Humans , Mice , Neoplasm Transplantation , Neovascularization, Pathologic/pathology
2.
Pol J Pathol ; 65(2): 135-40, 2014 Jun.
Article in English | MEDLINE | ID: mdl-25119174

ABSTRACT

Most patients with gastric cancer are diagnosed at advanced clinical stages with a high frequency of lymph node metastasis. It is very important to find novel factors for the early diagnostic and prognostic evaluation of gastric cancer. It has been shown that IGF-1R activates mitotic division and inhibits apoptosis of cancer cells through the activation of signaling MAP/ERK and PI3K/Akt-1 pathways. IGF-1R plays a role in cell transformation and maintenance of the phenotype in modified cells. Moreover, an IGF-1 receptor effect influences the processes of adhesion, migration, invasion and metastasis of tumor cells. The aim of the study was to assess the expression of IGF-1R in gastric carcinoma in correlation with selected anatomo-clinical parameters. The study enrolled a group of 49 patients treated surgically for gastric cancer. 28 patients had no lymph node metastases. The expression of the studied proteins was assessed using the immunohistochemical method. We found that the expression of IGF-1R in gastric cancer is associated with lymph node metastasis (p < 0.001), is correlated with worse prognosis and high histological malignancy grade, and is an independent predictor of survival in patients with gastric cancer (p < 0.001). IGF-1R may play an important role in tumor growth and metastasis via the lymphatic pathway.


Subject(s)
Biomarkers, Tumor/analysis , Carcinoma/chemistry , Carcinoma/secondary , Receptor, IGF Type 1/analysis , Stomach Neoplasms/chemistry , Stomach Neoplasms/pathology , Aged , Biopsy , Carcinoma/mortality , Female , Humans , Immunohistochemistry , Lymphatic Metastasis , Male , Middle Aged , Neoplasm Grading , Stomach Neoplasms/mortality , Survival Analysis
3.
Pol J Pathol ; 65(4): 296-304, 2014 Dec.
Article in English | MEDLINE | ID: mdl-25693084

ABSTRACT

Tissue inhibitor of metalloproteinase-1 (TIMP-1) inhibits the ability of cancer cells to metastasize, but it can also stimulate cancer development. The aim of this study was to assess the level of TIMP-1 in serum and its expression in patients with colorectal cancer (CRC). The study group consisted of 43 patients diagnosed with colorectal cancer and 24 healthy volunteers. The level of TIMP-1 was assessed by the ELISA method while the expression of this protein was performed immunohistochemically. The concentration of TIMP-1 in the sera of colorectal cancer patients was significantly higher than in the healthy control group (p = 0.004). Higher level of TIMP-1 in the sera correlated with female gender (p = 0.045), tumor location in colon (p = 0.016), poorly differentiated tumor (p = 0.034) and higher platelet count in whole blood (p < 0.004). A positive reaction of the protein in cancer cells was observed in 31 cases and was found to correlate negatively with its reaction in peritumoral stroma (p < 0.001). According to this study, TIMP-1 protein may play an important role in cancer development. The assessment of this molecule in serum and tissue can be useful at the time of diagnosis and can help us to understand the nature of colorectal pathogenesis.


Subject(s)
Adenocarcinoma/blood , Biomarkers, Tumor/blood , Colorectal Neoplasms/blood , Tissue Inhibitor of Metalloproteinase-1/blood , Adult , Aged , Aged, 80 and over , Case-Control Studies , Female , Humans , Immunohistochemistry , Male , Middle Aged
4.
Adv Med Sci ; 58(2): 221-6, 2013.
Article in English | MEDLINE | ID: mdl-23729584

ABSTRACT

PURPOSE: We identify the expression of PRL-3 in primary endometrioid endometrial cancer and metastases in relation to the clinicopathological characteristics. MATERIAL/METHODS: The study involved 30 patients with type I endometrial cancer. Twelve of them were diagnosed with metastases in various localization of abdomen. The PRL-3 expression was evaluated on the basis of immunohistochemistry results by the use of monoclonal antibody anti-PRL3 clone 3B6. RESULTS: The intensity of PRL-3 expression in correlation with tumor stage was statistically significant (p = 0.024). The strongest reaction was noted in cases classified as a 1a and 1b stage defined by FIGO. The strength of PRL-3 expression is significantly associated with the degree of histological tumor grade (p = 0.035). CONCLUSIONS: The strong expression of PRL-3 in the primary tumor that was significantly correlated with the grade and clinical stage suggest that PTP4A3 participates in the process of endometrial carcinogenesis.


Subject(s)
Carcinoma, Endometrioid/enzymology , Endometrial Neoplasms/enzymology , Neoplasm Proteins/metabolism , Protein Tyrosine Phosphatases/metabolism , Adult , Aged , Aged, 80 and over , Antibodies, Monoclonal/pharmacology , Carcinoma, Endometrioid/secondary , Endometrial Neoplasms/pathology , Female , Humans , Immunohistochemistry , Lymph Nodes/enzymology , Lymph Nodes/pathology , Lymphatic Metastasis , Middle Aged , Neoplasm Proteins/immunology , Neoplasm Staging , Prognosis , Protein Tyrosine Phosphatases/immunology
5.
Adv Med Sci ; 58(2): 235-43, 2013.
Article in English | MEDLINE | ID: mdl-24384769

ABSTRACT

BACKGROUND: Matrix metalloproteinase 2 (MMP-2) is able to degrade type IV collagen and its activity is mostly regulated by tissue inhibitor of matrix metalloproteinase 2 (TIMP-2). These proteins might play a role in tumor progression, including gastric cancer (GC). METHODS: The study included 108 individuals, GC patients and healthy subjects. Serum levels of all analyzed markers were evaluated by the immunological methods, while immunohistochemistry was used to assess the expression of these proteins in GC, interstitial inflammatory cells and normal tissues. RESULTS: The percentage of positive reactions of MMP-2 and TIMP-2 was higher in GC and inflammatory cells compared to normal tissue, while serum levels of these proteins were statistically lower in GC patients in comparison to healthy subjects. There was a significant positive correlation between TIMP-2 immunoreactivity in inflammatory cells and the presence of lymph node metastasis. Area under ROC curve (AUC) for TIMP-2 was higher than MMP-2, while serum MMP-2 was an independent prognostic factor of GC patients' survival. CONCLUSION: Our findings suggest that TIMP-2 seems to be a predictor of tumor progression, especially for nodal involvement, whereas serum MMP-2 might be useful as an independent prognostic factor of patients' survival.


Subject(s)
Gastritis/metabolism , Matrix Metalloproteinase 2/metabolism , Stomach Neoplasms/metabolism , Tissue Inhibitor of Metalloproteinase-2/metabolism , Adult , Aged , Aged, 80 and over , Biomarkers, Tumor/blood , Biomarkers, Tumor/metabolism , Female , Gastritis/mortality , Gastritis/pathology , Humans , Kaplan-Meier Estimate , Lymphatic Metastasis , Male , Matrix Metalloproteinase 2/blood , Middle Aged , Neoplasm Staging , Prognosis , ROC Curve , Stomach Neoplasms/mortality , Stomach Neoplasms/secondary , Tissue Inhibitor of Metalloproteinase-2/blood , Young Adult
6.
Adv Med Sci ; 57(1): 77-83, 2012 Jun 01.
Article in English | MEDLINE | ID: mdl-22440942

ABSTRACT

PURPOSE: The p53 protein as well as Bcl-2 family proteins such as Bax, Bak and Bcl-xL regulate apoptosis. The study objective was to analyze the expression of p53, Bak, Bcl-xL and Bax in gastric cancer and in healthy gastric mucosa. MATERIAL AND METHODS: The study group consisted of 66 patients with gastric cancer, treated surgically in II Department of General and Gastroenterological Surgery, Medical University of Bialystok. The expression of the studied proteins was assessed using the immunohistochemical method. RESULTS: Significant differences were found in the expressions of the studied proteins as compared to healthy gastric mucosa. The expressions of p53 and Bax were significantly higher (70% vs 13% and 50% vs 13%), whereas those of Bak and Bcl-xL significantly lower (18% vs 83% and 74% vs 97%) in cancer cells than in normal mucosa (p<0.001). Significant differences were also noted in the expressions of Bax and Bcl-xL in relation to histological type. In the intestinal type (Lauren I), the expressions of Bax and Bcl-xL were higher as compared to the diffuse type (Lauren II) (93% vs 43% and 91% vs 43%). Simultaneously, correlations were noted between changes in the expression of Bax vs Bcl-xL and Bak. High expression of Bax showed a positive correlation with reduced Bak and Bcl-xL (p<0.05). Moreover, positive expression of p53 caused poorer distant survival of patients (p<0.05). CONCLUSION: Our study concluded that disturbances in the expression of p53, Bax, Bcl-xL and Bak proteins are associated with their involvement in the process of carcinogenesis in the stomach. It is suggesting that they might appeared in the early phase of carcinogenesis.


Subject(s)
Immunohistochemistry/methods , Stomach Neoplasms/metabolism , Tumor Suppressor Protein p53/metabolism , bcl-2 Homologous Antagonist-Killer Protein/metabolism , bcl-2-Associated X Protein/metabolism , bcl-X Protein/metabolism , Adult , Aged , Apoptosis , Female , Humans , In Vitro Techniques , Male , Middle Aged
7.
Adv Med Sci ; 56(1): 39-43, 2011.
Article in English | MEDLINE | ID: mdl-21555304

ABSTRACT

PURPOSE: The aim of the study was to evaluate immunohistochemical expression of PRL-3 protein tumor buds, invasion front, central region of tumor and metastases of colorectal cancer. MATERIAL/METHODS: The PRL-3 expression was analyzed in 103 colorectal carcinoma patients, using the immunohistochemical method with a monoclonal antibody 3B6 anti-PRL-3 (Attogen Biomedical Research, USA). RESULTS: Positive reaction for PRL-3 was observed in 36.9% of cases in the central region of tumor, in 64.3% in the invasion front, and in as many as 81.4% in buds (present in 70/103 cases), in 100% in metastases to local lymph nodes, in 100% in metastases to the liver and in 97.1% in metastases to the lungs. The findings indicate that cancer cells obtain this protein already in the early stages of metastasizing. PRL-3 is present not only in metastases to local lymph nodes but also to distant organs. It is likely that PRL-3 protein takes part in the initiation of metastasizing of cancer cells. Also the presence of lymph and blood vessel invasion was found only to correlate with increased percentage of patients with strong PRL-3 expression in tumor buds (p=0.046). CONCLUSION: Our results may suggests the participation of PRL-3 protein as a marker of the presence of colorectal cancer metastasis to the lymph nodes and distant metastases, which is independent of parameters such as gender and age of the patients, tumor location, histological type and grade of histological malignancy and stage of tumor.


Subject(s)
Carcinoma/metabolism , Carcinoma/secondary , Colorectal Neoplasms/metabolism , Neoplasm Proteins/metabolism , Protein Tyrosine Phosphatases/metabolism , Biomarkers, Tumor/metabolism , Carcinoma/pathology , Colorectal Neoplasms/pathology , Female , Humans , Immunohistochemistry , Liver Neoplasms/metabolism , Liver Neoplasms/pathology , Liver Neoplasms/secondary , Lung Neoplasms/metabolism , Lung Neoplasms/pathology , Lung Neoplasms/secondary , Lymphatic Metastasis/pathology , Male , Middle Aged , Retrospective Studies
8.
Adv Med Sci ; 55(2): 167-71, 2010.
Article in English | MEDLINE | ID: mdl-20934966

ABSTRACT

PURPOSE: Helicobacter pylori present in the oral cavity can be a source of gastric infection. Since in the oral cavity H. pylori is mostly found in dental plaque, the aim of the study was to determine whether the oral health status and oral hygiene practices affect the incidence of H. pylori antigens in dental plaque. MATERIALS AND METHODS: The study was performed in 155 patients aged 19-78 years. Patients who had taken antibiotics within 4 weeks preceding the study and those with a past history of H. pylori eradication were excluded. Each patient filled out a questionnaire on the procedures of dental plaque removal from natural teeth and dentures, and underwent oral examination. H. pylori antigens in supragingival plaque were determined by the immunological method with the use of a kit for detection of H. pylori antigens in stool samples. RESULTS: The presence of H. pylori antigens in dental plaque was found in 65.6% of the study subjects. The oral health status, frequency of dentist visits as well as the number and technique of dental plaque removal from natural teeth and dentures did not differ significantly between patients with infected and non-infected dental plaque. CONCLUSIONS: The occurrence of H. pylori antigens in dental plaque of natural teeth is not associated with oral health status or dental plaque removal practices from both natural teeth and removable dentures.


Subject(s)
Dental Plaque/microbiology , Helicobacter Infections/diagnosis , Helicobacter pylori/pathogenicity , Oral Health , Oral Hygiene , Adult , Aged , Female , Helicobacter pylori/isolation & purification , Humans , Male , Middle Aged , Young Adult
9.
Adv Med Sci ; 55(2): 161-6, 2010.
Article in English | MEDLINE | ID: mdl-20639184

ABSTRACT

PURPOSE: Culture is one of the methods used for detecting Helicobacter pylori in the stomach. However, since it is costly, labor-consuming, and in a number of infected subjects gives a false negative result, the procedure is not routinely used. The aim of the study was to analyze some of the factors that may affect the outcome of H. pylori culture from endoscopic gastric mucosal specimens. MATERIAL AND METHODS: The study was conducted in a group of 265 subjects. The culture of gastric mucosal specimens was verified by urease test and histological examination. If the culture result was not consistent with one or two verifying tests, an additional two tests were used, i.e. H. pylori antigens in stool samples and anti-H. pylori antibodies in blood serum. RESULTS: In patients infected with H. pylori (at least two positive diagnostic tests), the analysis of factors that may affect the culture outcome revealed that neither age, gender, smoking, history of eradication, endoscopic diagnosis, use of proton pump inhibitors, ultrasonography of the abdomen or chest radiology performed the day before or on the day of gastroscopy, nor preparation for colonoscopy using osmotic fluids 1-2 days prior to gastroscopy had an effect on the culture outcome. Only high activity of gastritis (neutrophil infiltration) and low bacterial load in gastric mucosal specimens as well as drinking alcohol and the use of histamine H2 receptor blockers reduced culture efficacy in infected subjects. CONCLUSIONS: High activity of gastritis, low bacterial load, drinking alcohol and the use of histamine H2 receptor blockers can be the cause of failed H. pylori culture from gastric mucosa in the infected subjects. These factors should be taken into consideration when qualifying patients for the test and interpreting the results.


Subject(s)
Gastric Mucosa/microbiology , Helicobacter Infections/diagnosis , Helicobacter Infections/microbiology , Helicobacter pylori/growth & development , Adult , Aged , Antibodies, Bacterial/blood , Antigens, Bacterial/analysis , Endoscopy, Gastrointestinal , Feces/microbiology , Female , Gastritis/microbiology , Gastritis/physiopathology , Helicobacter Infections/blood , Helicobacter pylori/immunology , Helicobacter pylori/isolation & purification , Humans , Male , Middle Aged , Young Adult
10.
Adv Med Sci ; 55(1): 59-66, 2010.
Article in English | MEDLINE | ID: mdl-20371431

ABSTRACT

PURPOSE: To assess whether there is a correlation between the severity of gastritis and concentration of chosen growth factors in the serum of children infected with H. pylori. MATERIAL AND METHODS: The study included 64 children of whom 50% (Group I) were infected with H. pylori and had gastritis; 18.7% (Group II) of the examined children had a positive titre of IgG against H. pylori and normal gastric mucosa. Controls (Group III) comprised 31.3%. The gastric mucosa was evaluated histopathologically according to the Sydney System. The serum concentrations of growth factors: EGF, TGF-alpha, VEGF, were determined using ELISA. RESULTS: Mean concentrations of the growth factors were also the highest in Group I compared to Group II and Group III (EGF - 137.3+/-10.4 pg/mL, TGF-alpha - 0.4+/-1.2 pg/mL, VEGF - 146.8 pg/mL). Analysis of correlations between growth factors and the severity of gastritis as well as the activity of antral gastric mucosa inflammation proved that mean EGF concentration in H. pylori infected children was the highest (149.5+/-84.8 pg/mL) in severe gastritis, whereas mean concentrations of TGF-alpha (2.0+/-4.3 pg/mL) and of VEGF (148.1+/-92.6 pg/mL) were the highest in moderate gastritis. Mean concentrations of EGF (155.1+/-116.4 pg/mL) and of VEGF (156.0+/-118.9 pg/mL) were the highest in high activity antral gastritis, whereas the mean concentration of TGF-alpha was the highest (2.0+/-4.2 pg/ml) in moderate activity gastritis. CONCLUSIONS: In the children with H. pylori infection, serum concentrations of EGF, TGF-alpha, VEGF were the highest in moderate and severe antral gastritis.


Subject(s)
Gastric Mucosa/immunology , Gastric Mucosa/microbiology , Gastritis/blood , Gastritis/microbiology , Intercellular Signaling Peptides and Proteins/blood , Adolescent , Child , Child, Preschool , Enzyme-Linked Immunosorbent Assay , Epidermal Growth Factor/blood , Helicobacter Infections/microbiology , Helicobacter Infections/physiopathology , Humans , Infant , Transforming Growth Factor alpha/blood , Vascular Endothelial Growth Factor A/blood
11.
Adv Med Sci ; 54(2): 194-8, 2009.
Article in English | MEDLINE | ID: mdl-20034921

ABSTRACT

PURPOSE: The aim of this study was to determine the viability of the commercial test currently used for detection of H. pylori antigens in the stool for detection of H. pylori antigens in dental plaque. MATERIALS AND METHODS: A total of 164 dyspeptic patients entered the study; 95 H. pylori infected (positive result of at least 4 of 5 diagnostic tests: Campylobacter-like organisms test (CLO test), histology, culture, stool antigens, serology) and 69 noninfected (negative results of 4 diagnostic tests: CLO test, histology, culture, stool antigens). Dental plaque was collected from natural teeth of the patients and incubated in microaerophilic conditions for 72 hours before immunoassay. RESULTS: Experimental findings included that optimal dental plaque weight to perform the examination was over 2 mg and that preliminary incubation increased significantly the number of positive results (p<0.002). It was also found that H. pylori antigens in the dental plaque were positive in 81.2% of infected and only 17.7% of non-infected subjects (p<0.001), while the reproducibility of results was 95%. CONCLUSIONS: The immunoassay for detection of H. pylori antigens in the stool may be used, after minor adaptations (specifically pre-incubation in microaerophilic conditions) for H. pylori antigen detection in dental plaque.


Subject(s)
Antigens, Bacterial/analysis , Dental Plaque/immunology , Helicobacter pylori/immunology , Adult , Aged , Antigens, Bacterial/blood , Bacteriological Techniques , Biopsy , Campylobacter/immunology , Dental Plaque/microbiology , Dyspepsia/microbiology , Feces/microbiology , Female , Gastric Mucosa/microbiology , Gastric Mucosa/pathology , Gastroscopy , Helicobacter Infections/immunology , Humans , Immunoassay , Immunoglobulin A/analysis , Immunoglobulin G/analysis , Male , Middle Aged , Reproducibility of Results , Young Adult
12.
Adv Med Sci ; 54(2): 187-93, 2009.
Article in English | MEDLINE | ID: mdl-20034922

ABSTRACT

PURPOSE: Epidermal growth factor receptor (EGFR) modulates balance between proliferation and apoptosis in gastric mucosa of the gastrointestinal tract. The aim of the study was to evaluate immunohistochemically the EGFR expression in epithelial and gland cells of antral mucosa in children infected with Helicobacter pylori (H. pylori). MATERIAL/METHODS: The study included 44 children, aged from 5 to 18 years (mean age 13+/-3.4 years) with dyspeptic symptoms, of whom 30 (68.2%) children were infected with H. pylori, 14 (31.8%) children constituted controls. Endoscopic and histopathological assessment of antral mucosa samples was performed according to the Sydney System. Samples taken from gastroscopy were prepared to evaluate EGFR expression in epithelial and gland cells of antrum mucosa according to the manual of a detection kit of EnVision+System-HRP (DAKO). RESULTS: In children H. pylori infected, the EGFR expression in epithelial cells of antral mucosa equaled on average 82.5+/-15 cells/mm2 and ranged from 45.0 to 98.0 cells/mm2 as well as differed statistically significantly when compared to controls (10.2+/-5.0 cells/mm2) (p<0.001). In children with H. pylori infection, the EGFR expression in gland cells of antral mucosa ranged from 2.0 to 85.0 cells/mm2 (mean 25.7+/-22.6 cells/mm2); was lower and differed statistically significantly from controls (54.2 +/- 29.6 cells/mm2) (p<0.001). In children H. pylori infected, there was a statistically significant difference (p<0.001) between the EGFR expression in epithelial and in gland cells of antral mucosa. CONCLUSION: The increased EGFR expression in epithelial cells in comparison with gland cells of antral mucosa in children with H. pylori infection may suggest its role in regeneration processes of gastric mucosa.


Subject(s)
ErbB Receptors/analysis , Gastric Mucosa/microbiology , Gastritis/microbiology , Helicobacter Infections/pathology , Helicobacter pylori/isolation & purification , Adolescent , Biopsy , Cell Count , Child , Child, Preschool , Chronic Disease , Dyspepsia/microbiology , Epithelial Cells/microbiology , Epithelial Cells/pathology , Feeding and Eating Disorders/microbiology , Gastric Mucosa/pathology , Gastritis/classification , Gastritis/pathology , Gastroscopy , Helicobacter Infections/classification , Humans , Nausea/microbiology , Pyloric Antrum/microbiology , Pyloric Antrum/pathology , Vomiting/microbiology
13.
Dis Esophagus ; 22(4): 368-73, 2009.
Article in English | MEDLINE | ID: mdl-19222537

ABSTRACT

In some populations, Helicobacter pylori eradication is associated with development of erosive esophagitis. The aim of this study was to evaluate the contribution of salivary bicarbonate and glycoprotein secretion to the pathogenesis of erosive esophagitis developing after H. pylori eradication. Gastroscopy and saliva collection were performed at recruitment and 12 months after completion of eradication therapy. Eighty-eight patients with duodenal ulcer were recruited to the study. Erosive esophagitis was found in 13 patients (grade A, 8 patients; grade B, 4 patients; grade C, 1 patient). Among the 74 subjects who completed the study, erosive esophagitis was detected in 21 patients (grade A, 15 patients; grade B, 6 patients); they all were successfully eradicated. Bicarbonate and glycoprotein secretion was not found to differ significantly between the subjects with and without erosive esophagitis both before and 1 year after H. pylori eradication. However, it was lower in H. pylori-infected (baseline) than in H. pylori-noninfected erosive esophagitis subjects (1 year after successful eradication) (bicarbonate 2.34 [1.29-3.40)]vs. 3.64 [2.70-4.58]micromol/min and glycoprotein 0.23 [0.15-0.31]vs. 0.35 [0.28-0.43] mg/min, P= 0.04 and P= 0.04, respectively). We conclude that changes in salivary bicarbonate and glycoprotein secretion related to H. pylori eradication do not promote the development of erosive esophagitis in duodenal ulcer patients.


Subject(s)
Duodenal Ulcer/epidemiology , Esophagitis, Peptic/epidemiology , Helicobacter Infections/drug therapy , Helicobacter Infections/epidemiology , Helicobacter pylori/drug effects , Saliva/chemistry , Adolescent , Adult , Aged , Anti-Bacterial Agents/administration & dosage , Anti-Ulcer Agents/therapeutic use , Bicarbonates/chemistry , Breath Tests , Cohort Studies , Comorbidity , Drug Therapy, Combination , Duodenal Ulcer/diagnosis , Duodenal Ulcer/drug therapy , Esophagitis, Peptic/diagnosis , Esophagitis, Peptic/drug therapy , Esophagoscopy/methods , Glycoproteins/metabolism , Helicobacter Infections/diagnosis , Helicobacter pylori/isolation & purification , Humans , Middle Aged , Probability , Prognosis , Saliva/metabolism , Severity of Illness Index , Statistics, Nonparametric , Treatment Outcome , Young Adult
14.
Adv Med Sci ; 53(2): 305-9, 2008.
Article in English | MEDLINE | ID: mdl-18930874

ABSTRACT

PURPOSE: Erosive esophagitis frequently develops after successful Helicobacter pylori eradication. Since salivary secretion of epidermal growth factor (EGF) plays a crucial role in the pathogenesis of gastroesophageal reflux disease, the current study objective was to find out whether erosive esophagitis development after Helicobacter pylori eradication is associated with the secretion of EGF in saliva. MATERIALS AND METHODS: A total of 115 H. pylori infected patients (positive results of CLO-test, histology and serology) with a duodenal ulcer were recruited for the study. Gastroscopic examinations and saliva collections were performed twice, prior to H. pylori eradication and one year after its cessation. The salivary EGF was determined using a radioimmunological method. RESULTS: Salivary EGF secretion was lower in H. pylori infected subjects with erosive esophagitis than without (0.82+/-0.66 vs 1.70+/-3.49 ng/min, p=0.021). However, a year after successful H. pylori eradication, salivary EGF did not differ between the groups (2.17+/-2.06 vs 1.79+/-2.06 ng/min); the lack of difference was due to high peptide secretion in patients who developed erosive esophagitis after eradication. CONCLUSION: Erosive esophagitis development following H. pylori eradication is not the result of decreased salivary EGF secretion.


Subject(s)
Duodenal Ulcer/metabolism , Duodenal Ulcer/microbiology , Epidermal Growth Factor/metabolism , Esophagitis/metabolism , Helicobacter Infections/prevention & control , Helicobacter pylori , Saliva/metabolism , Adolescent , Adult , Aged , Duodenal Ulcer/prevention & control , Esophagitis/etiology , Female , Follow-Up Studies , Humans , Male , Middle Aged , Young Adult
15.
Adv Med Sci ; 53(2): 310-5, 2008.
Article in English | MEDLINE | ID: mdl-18952538

ABSTRACT

PURPOSE: The aim of the study was to evaluate the effect of smoking and drinking habits, in separate and joint analyses, on the efficacy of H. pylori eradication. MATERIALS AND METHODS: A total of 250 patients were recruited. They were treated with a 7-day course of omeprazole, amoxicillin, tinidazole (OAT), omeprazole amoxicillin, clarithromycin (OAC) or omeprazole, clarithromycin, tinidazole (OCT). The efficacy of H. pylori eradication was tested with a CLO-test and histology 4 weeks after the completion of antibacterial therapy. RESULTS: Drinking was found not to affect the efficacy of H. pylori eradication in any therapeutic group, while smoking decreased it in the OAC group (smokers 69.6%, non-smokers 94.3%, p=0.006). In the OAT treated group H. pylori eradication rate was lower in smokers-non-drinkers than in smokers-drinkers and non-smokers-non-drinkers (38.9% vs 83.2% and 70.0%, p=0.002 and p=0.034, respectively), while in the OAC treated group, smokers-non-drinkers had lower eradication efficacy than non-smokers-drinkers and non-smokers-non-drinkers (59.1% vs 100% and 91.3%, p=0.01 and p=0.012, respectively). In the OCT treated group, differences between subgroups were not significant. CONCLUSIONS: Smoking and drinking habits when analyzed jointly are more useful to predict the outcome of H. pylori eradication than when analyzed separately.


Subject(s)
Alcohol Drinking/epidemiology , Duodenal Ulcer/microbiology , Helicobacter Infections/diagnosis , Helicobacter Infections/drug therapy , Helicobacter pylori/drug effects , Peptic Ulcer/microbiology , Smoking/epidemiology , Anti-Bacterial Agents/therapeutic use , Anti-Ulcer Agents/therapeutic use , Drug Therapy, Combination , Duodenal Ulcer/drug therapy , Female , Humans , Male , Middle Aged , Peptic Ulcer/drug therapy , Predictive Value of Tests
16.
Adv Med Sci ; 52: 191-5, 2007.
Article in English | MEDLINE | ID: mdl-18217417

ABSTRACT

PURPOSE: Long-term cigarette smoking may increase the risk of digestive tract pathologies, however, what is the influence smoking habit on gastric mucosa histology is still poorly elicited. The aim of the study was to compare histological evaluation of gastritis in smoker and non-smoker groups. MATERIAL AND METHODS: A total of 236 patients of various H. pylori status (109 infected, 127 non-infected), clinical diagnosis (107 duodenal ulcer disease, 129 dyspepsia), and smoking habit (92 smokers, 144 non-smokers) were included. Subjects were classified as smokers if they smoked 5 or more cigarettes per day for at least 3 years. A histological examination of endoscopically obtained samples was performed by two experienced pathomorphologists blinded to the diagnoses and smoking habit. Microscopic slices of the gastric mucosa were stained with hematoxylin-eosin and Giemsa. Apart from histological diagnosis, H. pylori status was additionally confirmed by an urease test (CLO-test) at least in one of two gastric locations (antrum or corpus). RESULTS: In the H. pylori infected population, H. pylori density, neutrophils, and mononuclear cells infiltration in the gastric corpus mucosa were lower in smokers than non-smokers, while in the antrum the differences were not significant. In the non-infected population, no significant differences in neutrophils and mononuclear cells infiltration between smokers and non-smokers were found. CONCLUSIONS: Since the significant differences in studied parameters of chronic gastritis between smokers and non-smokers were found in the corpus mucosa of H. pylori infected subjects, smoking should be taken into account when a histological evaluation of the gastric mucosa in the H. pylori infected population is performed.


Subject(s)
Gastritis/diagnosis , Gastritis/etiology , Smoking , Adult , Duodenal Ulcer/diagnosis , Duodenal Ulcer/microbiology , Dyspepsia/diagnosis , Dyspepsia/microbiology , Female , Gastric Mucosa/microbiology , Gastric Mucosa/pathology , Gastritis/microbiology , Helicobacter Infections/diagnosis , Helicobacter Infections/microbiology , Helicobacter pylori/metabolism , Humans , Male , Middle Aged
17.
Adv Med Sci ; 51: 137-41, 2006.
Article in English | MEDLINE | ID: mdl-17357294

ABSTRACT

PURPOSE: Impaired control of gastric juice secretion is observed in chronic gastritis due to Helicobacter pylori (H. pylori) infection. G cells are stimulated by such cytokines as tumor necrosis factor (TNF-alpha), interferon gamma (IFN-gamma) and interleukin-8 (IL-8). The number of D cells producing somatostatin decreases simultaneously. An increase in gastrin levels could also depend on alkalization in G cell environment caused by bacterial urease. The aim of the study was to evaluate G cell counts in the antrum and gastrin levels in the serum of children with H. pylori infection and after bacterium eradication. MATERIAL AND METHODS: The study was performed in 106 patients. Children were divided into 3 groups with regard to the presence and course of H. pylori infection. Fifty nine children (55.7%) had chronic gastritis in the course of H. pylori infection with a positive titre of antibodies in IgG class against H. pylori; 29 children (27.3%) with past H. pylori infection, without bacterium colonization and gastritis but with a positive titre of antibodies in IgG class against H. pylori; 18 children (17%) with functional disorders of the gastrointestinal tract but without H. pylori infection. RESULTS: The quantitative analysis of gastrin cells in the antral mucosa of children performed by immunohistochemical method showed the highest gastrin cell count in group I with H. pylori infection (112.1 +/- 58.9 cell/mm2) and in group II with past H. pylori infection (105.3 +/- 73.1 cell/mm2). The serum gastrin level (92.9 +/- 41.6 microU/ml) was the highest in children with H. pylori infection. In controls, it was 70.0 +/- 15.3 microU/ml and could be compared to the results of children with past H. pylori infection. CONCLUSIONS: 1. The H. pylori infection plays a significant role in the stimulation of G cells increase and gastrin release in the blood serum in children. 2. The eradication of H. pylori infection is probably a main factor in gastric secretion down-regulation during gastritis in children.


Subject(s)
Gastrin-Secreting Cells/metabolism , Gastrins/blood , Helicobacter Infections/blood , Helicobacter pylori , Adolescent , Child , Child, Preschool , Female , Gastric Mucosa/metabolism , Gastric Mucosa/microbiology , Gastric Mucosa/pathology , Gastrin-Secreting Cells/microbiology , Helicobacter Infections/metabolism , Helicobacter Infections/microbiology , Humans , Immunohistochemistry , Male
18.
Adv Med Sci ; 51: 153-5, 2006.
Article in English | MEDLINE | ID: mdl-17357297

ABSTRACT

PURPOSE: Helicobacter pylori infection plays a crucial role in pathogenesis of peptic ulcers; however, among infected individuals only a small percentage will develop peptic ulcers at any time during their life. This low virulence suggests that many additional factors beside H. pylori are implicated in pathogenesis of the disease. The aim of the study was to determine whether there is a relationship between the prevalence of peptic ulcers and oral health status. MATERIAL AND METHODS: The evaluation of dental status was performed in H. pylori infected population. The study involved 93 peptic ulcer patients (77 duodenal ulcer, 16 gastric ulcer) with ulcer niche not related to non-steroidal anti-inflammatory drugs (NSAIDs) consumption and 93 gender and age matched dyspeptic controls. H. pylori infection was determined in endoscopically taken slices from gastric mucosa with two methods (CLO-test and histology). RESULTS: Both in duodenal and gastric ulcer patients, the number of filled teeth was lower and debris index was higher than in controls, the number of decayed teeth was also higher in gastric ulcer patients. The number of natural teeth, number and type of prosthetic restorations, as well as the periodontal index, did not differ between the ulcer and control groups. Poor oral health in patients with peptic ulcers corresponded with education level, smoking habit, and visits to the dentist. CONCLUSIONS: Poor oral health is associated with the prevalence of peptic ulcers not related to NSAIDs consumption, but it appears doubtful that it is a significant pathogenetic factor in ulcer disease.


Subject(s)
Helicobacter Infections/complications , Oral Health/standards , Peptic Ulcer/pathology , Stomach Ulcer/pathology , Adult , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Female , Gastric Mucosa/drug effects , Gastric Mucosa/microbiology , Gastric Mucosa/pathology , Helicobacter Infections/microbiology , Humans , Male , Middle Aged , Oral Hygiene/standards , Peptic Ulcer/etiology , Stomach Ulcer/etiology
19.
Rocz Akad Med Bialymst ; 49 Suppl 1: 40-2, 2004.
Article in English | MEDLINE | ID: mdl-15638369

ABSTRACT

The aim of the study was to evaluate the correlation of c-erb-b2 and Bcl-xl expression in biopsy specimens of Barrett's oesophagus from 44 patients with morphological features. The examined group was subdivided into: negative for dysplasia, indefinite for dysplasia, positive for dysplasia-low grade, and adenocarcinoma with high grade dysplasia. Positive c-erb-B2 staining was found in 34.1% and Bcl-xl protein expression was observed in 96.9% of BE. The results showed increased c-erb-B2 and Bcl-xl protein expressions with progressive grades of dysplasia to adenocarcinoma. In conclusion, an evaluation of c-erb-B2 and Bcl-xl expression can be useful for the histopatologic diagnosis of BE and correct interpretation of dysplasia.


Subject(s)
Barrett Esophagus/pathology , Proto-Oncogene Proteins c-bcl-2/metabolism , Receptor, ErbB-2/metabolism , Adenocarcinoma/pathology , Apoptosis , Humans , Intestinal Neoplasms/pathology , Retrospective Studies , bcl-X Protein
20.
Rocz Akad Med Bialymst ; 49 Suppl 1: 64-6, 2004.
Article in English | MEDLINE | ID: mdl-15638377

ABSTRACT

Tumours from 45 patients with advanced gastric cancer were assessed by immunohistochemistry. Tissue sections were fixed in 10% buffered formaldehyde solution, embedded in paraffin and stained immunohistochemically with anti-human Ki-67 and PCNA antibodies. No correlation was found between Ki-67, PCNA protein expression, the age of patients and the localization of tumour. A significant, positive association was observed between the expression of Ki-67, PCNA and tumour differentiation and Lauren's classification. Also a strong correlation was found between lymph node involvement and the expression of Ki-67 protein. These data suggest that the expression of Ki-67, PCNA proteins were closely connected with the high grade of tumour malignancy.


Subject(s)
Ki-67 Antigen/analysis , Proliferating Cell Nuclear Antigen/analysis , Stomach Neoplasms/pathology , Female , Humans , Male , Neoplasm Staging , Stomach Neoplasms/surgery
SELECTION OF CITATIONS
SEARCH DETAIL
...